Advances and prospects of drug clinical research in colorectal cancer in 2022

Abstract Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death worldwide. Clinical research results have provided more treatment opportunities for CRC patients, showing that an optimal combination of existing drugs and new drugs is needed to mitigate th...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Dan Su, Chao Liu, Jie Cui, Jiebing Tang, Yuli Ruan, Yanqiao Zhang
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Wiley 2023-04-01
Σειρά:Cancer Innovation
Θέματα:
Διαθέσιμο Online:https://doi.org/10.1002/cai2.62